CRDF FY 2011 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$133M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$257,696-3.0% YoY

Gross Profit

$257,696100.0% margin

Operating Income

-$3M-1155.2% margin

Net Income

-$2M-868.9% margin

EPS (Diluted)

$-16.60

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$250,978

Balance Sheet

Total Assets

$1M

Total Liabilities

$5M

Stockholders' Equity

-$4M

Cash & Equivalents

$700,374

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$257,696	$265,665	-3.0%
Gross Profit	$257,696	$265,665	-3.0%
Operating Income	-$3M	-$5M	+44.7%
Net Income	-$2M	-$5M	+58.9%